LOXL2 in anabolic response to chondrodysplasia mice progressive TMJ and knee osteoarthritis
Osteoarthritis (OA) is a degenerative joint disease that affects an estimated 9.6 % of men and 18 % of women over 60 years of age. However, there is no chondroprotective agent that is approved for clinical application. We showed that LOXL2 is elevated in the regenerative response during fracture he...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/37013 |